A randomized double-blind controlled study of laninamivir comparing with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases

Trial Profile

A randomized double-blind controlled study of laninamivir comparing with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2016

At a glance

  • Drugs Laninamivir (Primary) ; Oseltamivir
  • Indications Respiration disorders
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 27 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top